BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35600374)

  • 1. Nomogram Predicts the Role of Primary Tumor Surgery on
    Cui H; Dai L; Bao Y; Hu L; Zhou Z; Wang M; Lin S; Wu H; Ma X; Kang H
    Front Oncol; 2022; 12():819531. PubMed ID: 35600374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic Pattern Discriminates Survival Benefit of Type of Surgery in Patients With
    Li K; Zhou C; Yu Y; Niu L; Zhang W; Wang B; He J; Ge G
    Front Surg; 2021; 8():696628. PubMed ID: 34805256
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival Comparisons between Breast Conservation Surgery and Mastectomy Followed by Postoperative Radiotherapy in Stage I-III Breast Cancer Patients: Analysis of the Surveillance, Epidemiology, and End Results (Seer) Program Database.
    Xiang W; Wu C; Wu H; Fang S; Liu N; Yu H
    Curr Oncol; 2022 Aug; 29(8):5731-5747. PubMed ID: 36005190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic effect of radiotherapy in breast cancer patients underwent immediate reconstruction after mastectomy.
    Dai L; Cui H; Bao Y; Hu L; Zhou Z; Lin S; Zhang X; Wu H; Kang H; Ma X
    Front Oncol; 2022; 12():1010088. PubMed ID: 36408183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of breast-conserving surgery without radiotherapy and mastectomy in the treatment of elderly patients with early breast cancer: A PSM and SEER database study.
    Fu B; Chen X; Liang W; Wang Y; Yao Y; Zhang J
    Cancer Med; 2023 Jul; 12(14):15229-15245. PubMed ID: 37269188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Nomogram and Risk Classification System Predicting the Prognosis of Patients with De Novo Metastatic Breast Cancer Undergoing Immediate Breast Reconstruction: A Surveillance, Epidemiology, and End Results Population-Based Study.
    Zhao J; Bian S; Di X; Xiao C
    Curr Oncol; 2023 Dec; 31(1):115-131. PubMed ID: 38248093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic analysis of cT1-3N1M0 breast cancer patients who have responded to neoadjuvant therapy undergoing various axillary surgery and breast surgery based on propensity score matching and competitive risk model.
    Zhang M; Sun Y; Wu H; Xiao J; Chen W; Wang H; Yang B; Luo H
    Front Oncol; 2024; 14():1319981. PubMed ID: 38327751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value and mode selection of locoregional treatment in Stage-IV breast cancer patients.
    Cui H; Ren X; Zhao X; Dai L; Liu D; Bao Y; Hu L; Xiao Z; Ma X; Kang H
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13591-13605. PubMed ID: 37515611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
    Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
    Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
    Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
    Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram Predicts the Role of Contralateral Prophylactic Mastectomy in Male Patients With Unilateral Breast Cancer Based on SEER Database: A Competing Risk Analysis.
    Li K; Wang B; Yang Z; Yu R; Chen H; Li Y; He J; Zhou C
    Front Oncol; 2021; 11():587797. PubMed ID: 33996535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study.
    Zhao W; Wu L; Zhao A; Zhang M; Tian Q; Shen Y; Wang F; Wang B; Wang L; Chen L; Zhao X; Dong D; Zhang L; Yang J
    BMC Cancer; 2020 Oct; 20(1):982. PubMed ID: 33046035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer.
    Chen MS; Liu PC; Yi JZ; Xu L; He T; Wu H; Yang JQ; Lv Q
    Sci Rep; 2022 Aug; 12(1):14659. PubMed ID: 36038627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for primary tumor benefits survival for breast cancer patients with bone metastases: a large cohort retrospective study.
    Huang Z; Zhou X; Tong Y; Zhu L; Zhao R; Huang X
    BMC Cancer; 2021 Mar; 21(1):222. PubMed ID: 33663462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of primary tumor surgery in
    Yang YS; Chen YL; Di GH; Jiang YZ; Shao ZM
    Transl Cancer Res; 2019 Apr; 8(2):614-625. PubMed ID: 35116794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective tool for predicting survival in breast cancer patients with
    Wang W; Liu J; Chen Y; Xu X; Huo L; Wang X; Gu J
    Front Surg; 2022; 9():939132. PubMed ID: 36684376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective comparative cohort study of SEER database analysis of the prognostic value of breast-conserving surgery and mastectomy in patients with multifocal multicenter breast cancer.
    Yu M; Xia L; Cao B; Wang M; Liu S; Liu S; Mou E; Li H; Wang H
    Gland Surg; 2023 Feb; 12(2):165-182. PubMed ID: 36915807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the survival benefit of local surgery in patients aged 70 years or older with stage IV breast cancer: A population-based analysis.
    Chen YQ; Xu JW; Xu XF; Wang XL; Huo LQ; Wang L; Zhou GH; Gu J
    Breast; 2021 Oct; 59():124-134. PubMed ID: 34229127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Survival Benefit of Sparing Sentinel Lymph Node Biopsy in Low-Risk Elderly Patients With Early Breast Cancer: A Population-Based Analysis.
    Xu L; Wen N; Qiu J; He T; Tan Q; Yang J; Du Z; Lv Q
    Front Oncol; 2020; 10():1718. PubMed ID: 33042815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.